Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse NF-kB p65 ELISA Kit (AC3335)
Cat.#: ASET-1924
Specifications
Description Mouse NF-kB p65 ELISA Kit allows for the in vitro quantitative determination of mouse NF-kB p65 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2175 Human NKCC1 ELISA Kit (AC3586) Quantitative inquiry ASET-1358 Human Cannabinoid Receptor II ELISA Kit (AC2769) Quantitative inquiry ASET-2420 Rat Orexin ELISA Kit (AC3831) Quantitative inquiry ASET-1909 Human Angiogenin ELISA Kit (AC3320) Quantitative inquiry ASET-1086 Rat DRD4 ELISA Kit (AC2497) Quantitative inquiry ASET-1463 Human Ornithine Aminotransferase ELISA Kit (AC2874) Quantitative inquiry ASET-1043 Mouse Glypican 4 ELISA Kit (AC2454) Quantitative inquiry ASET-1709 Canine alpha Synuclein ELISA Kit (AC3120) Quantitative inquiry ASET-1562 Rat PON1 ELISA Kit (AC2973) Quantitative inquiry ASET-1534 Human Apolipoprotein E ELISA Kit (AC2945) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket